Maturation-state dependent response of human periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro

Journal of Periodontal Research

Volumn 41, Issue 1, 2006, Pages 62-72

  Lossdorfer S ^a,b   Stier, S ^a   Gotz W ^a   Jager A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b DDS ^*  (Germany)

Author keywords

Human periodontal ligament cells; Intermittent parathyroid hormone exposure; Osteoprotegerin; Receptor activator of nuclear factor kappaB ligand

Indexed keywords

ALKALINE PHOSPHATASE; CARRIER PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; LIGAND; MEMBRANE PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ADOLESCENT; ARTICLE; BONE REMODELING; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; OSTEOBLAST; OSTEOCLAST; PERIODONTAL LIGAMENT; TIME;

ADOLESCENT; ALKALINE PHOSPHATASE; BONE REMODELING; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; FIBROBLASTS; GLYCOPROTEINS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE; PERIODONTAL LIGAMENT; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645059992     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00838.x     Document Type: Article

References (45)

1. Potts JT, Bringhurst FR, Gardella T et al. Parathyroid hormone, physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action. In: DeGroot LJ, ed. Endocrinology, 3rd edn, Vol. 2. Philadelphia: W.B. Saunders 1995: 920-966.
2. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 1997;99:2961-2970.
3. Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK. Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 2002;143:4038-4047.
4. Schiller PC, D'Ippolito G, Roos BA, Howard GA. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 1999;14:1504-1512.
5. Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999;140:3552-3561.
6. Iida-Klein A, Zhou H, Lu S et al. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 2002;17:808-816.
7. Yang ZJ, Cheng V, Barnes S, Cavalho L, Sindrey D. Pulsatile parathyroid hormone (PTH) treatment increases bone formation in vitro in fetal rat calvarial cell (FRCC) culture system. J Bone Miner Res 1997;12:S317.
8. Canalis E, Centrella M, Burch W, McCarthy TL. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 1989;83:60-65.
9. Rosen CJ, Bilezikian JP. Clinical review 123: Anabolic therapy for osteoporosis. J Clin Endocrinol Metab 2001;86:957-964.
10. Huang JC, Sakata T, Pfleger LL et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004;19:235-244.
11. Fu Q, Jilka R, Manolagas C, O'Brien C. Parathyroid hormone stimulates receptor activator of nuclear factor kappaB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 2002;277:48868-48875.
12. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999;104:439-446.
13. Stanislaus D, Yang X, Liang JD et al. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone 2000;27:209-218.
14. Sone T, Fukunaga M, Ono S, Nishiyama T. A small dose of human parathyroid hormone (1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Miner Electrolyte Metab 1995;21:232-235.
15. Lacey DL, Timms E, Tan HL at al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
16. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998;188:997-1001.
17. Kartsogiannis V, Zhou H, Horwood NJ et al. Localization of RANKL (receptor activator of NFkB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 1999;25:525-534.
18. Ouyang H, McCauley L, Berry J, D'Errico J, Strayhorn C, Somerman M. Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone related protein in vitro. Arch Oral Biol 2000;45:293-303.
19. Nohutcu RM, Somerman MJ, McCauley LK. Dexamethasone enhances the effects of parathyroid hormone on human periodontal ligament cells in vitro. Calcif Tissue Int 1995;56:571-577.
20. Tsuji K, Uno K, Zhang G, Tamura M. Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab 2004;22:94-103.
21. Lossdorfer S, Gotz W, Jager A. Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. Calcif Tiss Int 2002;71:45-52.
22. Chou AM, Sae-Lim V, Lim T et al. Culturing and characterization of human periodontal ligament fibroblasts-a preliminary study. Mater Sci Eng 2002;20:77-83.
23. Basdra EK, Komposch G. Osteoblast-like properties of human periodontal ligament cells: an in vitro analysis. Eur J Orthod 1997;19:615-621.
24. 3. Arch Oral Biol 2004;49:71-76.
25. 2 synthesis. J Bone Miner Res 2002;17:210-225.
26. Davidovitch Z, Musich D, Doyle M. Hormonal effects on orthodontic tooth movement in cats-a pilot study. Am J Orthod 1972;62:95-96.
27. Tenorio D, Hughes FJ. An immunohistochemical investigation of the expression of parathyroid hormone receptors in rat cementoblasts. Archs Oral Biol 1996;41:299-305.
28. Philbrick W, Dreyer B, Nakchbandi I, Karaplis A. Parathyroid hormone-related protein is required for tooth eruption. Proc Natl Acad Sci 1998;95:11846-11851.
29. Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop 2001;392:427-432.
30. 3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 1989;264:11879-11886.
31. Isogai Y, Akatsu T, Ishizuya T et al. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 1996;11:1384-1393.
32. Bretaudiere JP, Spillman T. Alkaline phosphatases. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Verlag Chemica, Weinheim, Germany 1984: 75-92.
33. Fedde KN, Cole DE, Whyte MP. Pseudohypophosphatasia: aberrant localization and substrate specificity of alkaline phosphatase in cultured skin fibroblasts. Am J Hum Genet 1990;47:776-783.
34. Thomson M, McCarroll J, Bond J, Gordon-Thomson C, Williams E, Moore GP. Parathyroid-hormone related peptide modulates signal pathways in skin and hair follicle cells. Exp Dermatol 2003;12:389-395.
35. Chen H, Demiralp B, Schneider A et al. Parathyroid hormone and parathyroid hormone-related protein exert both proand anti-apoptotic effects in mesenchymal cells. J Biol Chem 2002;277:19374-19381.
36. Wang YH, Liu Y, Buhl K, Rowe DW. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res 2005;20:5-14.
37. Swarthout JT, Doggett TA, Lemker JL, Partridge NC. Stimulation of of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid-hormone is proteinkinase-C dependent. J Biol Chem 2001;276:7586-7592.
38. Locklin RM, Khosla S, Turner RT, Riggs BL. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 2003;89:180-190.
39. Ma YL, Cain R, Halladay D et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 2001;142:4047-4054.
40. Buxton E, Yao W, Lane N. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab 2004;89:3332-3336.
41. Kostenuik PJ, Capparelli C, Morony S et al. OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. Endocrinology 2001;142:4295-4304.
42. Akatsu T, Murakami T, Nishikawa M et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 1998;250:229-234.
43. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast ineage cells is developmentally regulated. Endocrinology 2000; 141:4768-4776.
44. Granchi D, Cenni E, Savarino L et al. Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. Biomaterials 2002;23:2359-2365.
45. Kanzaki H, Chiba M, Shimizi Y, Mitani H. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res 2001;80:887-891.